Published in Gene Therapy Weekly, January 5th, 2006
According to a report from India, "Adverse effects of viral vectors, instability of naked DNA, cytotoxicity, and low transfection of cationic lipids, cationic polymers, and other synthetic vectors are currently severe limitations in gene therapy."
"In addition to targeting a specific cell type, an ideal nonviral vector must manifest an efficient endosomal escape, render sufficient protection of DNA in the cytosol and help provide an easy passage of cytosolic DNA to the nucleus. Virus-like size calcium phosphate nanoparticles have been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.